Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

Spotlight

01.08.15 Allena Pharmaceuticals to Present at 2015 J.P. Morgan Healthcare Conference

12.04.14 Allena Pharmaceuticals Secures $25 Million Series B Financing